Maternal gestational hypertension, smoking and pre-eclampsia are associated with metabolic dysfunction-associated fatty liver disease in overweight offspring

Introduction: Due to a steep increase in obesity, metabolic dysfunction-associated fatty liver disease (MAFLD) has also become the most common chronic hepatic condition among children and adolescents. Various maternal and pregnancy-related factors have also been implicated in the development of MAFLD, but human studies remain scarce. Material and methods: Comprehensive data of 460 overweight or obese children aged 2–16 years were collected and combined with data on selected maternal and pregnancy-related factors for a case–control study. MALFD was defined as alanine aminotransferase >2× upper limit of normal. Children with and without MAFLD were compared regarding to the study variables and multivariable regression analysis was utilized. Results: Median age of the study children was 11.8 (quartiles 9.1–14.2) years; 44% were girls and 17.8% had MAFLD. Children with MAFLD were older (12.7 vs. 11.6 years, p = 0.002), while the groups did not differ age-standardized body mass index (BMI-SDS) or gender. Factors associated with MAFLD in a multivariable model considering also the offspring's present BMI-SDS, sex, and maternal prepregnancy overweight, were child's older age (odds ratio [OR] 1.16, 95% confidence interval [CI]: 1.06–1.28), maternal gestational smoking (OR 2.01, 95% CI: 1.16–3.47), gestational hypertension (OR 3.44, 95% CI: 1.08–11.0) and pre-eclampsia (OR 2.93, 95% CI: 1.15–7.45). There was no significant association between MAFLD and maternal BMI, birth anthropometrics or perinatal complications. Conclusions: Maternal smoking, gestational hypertension and pre-eclampsia were associated with MAFLD among overweight or obese children. Further prospective studies are needed to verify causal relationships.